De Luna, Baby Girl .
HRN: 23-45-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/02/2023
09/09/2023
IV
35 Mg
Q24hrs
Perinatal Asphyxia, Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes